Near the end of the last May, University of Kansas student Nicole wanted to cut 30 pounds from her 5-foot-9, 173-pound frame. Her lifestyle at that time was not suitable to losing the weight. Diet pills presented a reasonable alternative.

The U.S. Food and Drug Administration is expected to rule soon on two new weight-loss pills.

An experiment reducing the level of a chemical in rats’ brains offers a promising strategy for new obesity drugs.

Stanford University scientists have discovered a potential new weapon in the battle of the bulge: a hormone that reduces the urge to eat.

Alizyme plc (LSE:AZM) has successfully completed its pharmacokinetic/pharmacodynamic clinical trial of cetilistat in obese volunteers, under its Investigational New Drug (IND) application in the USA.